Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ritu Ojha, Kunal Nepali, Chun Han Chen, Kuo Hsiang Chuang, Tung Yun Wu, Tony Eight Lin, Kai Cheng Hsu, Min Wu Chao, Mei Jung Lai, Mei Hsiang Lin, Han Li Huang, Chao Di Chang, Shiow Lin Pan, Mei Chuan Chen, Jing Ping Liou

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))'. Together they form a unique fingerprint.

Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions